MLPA® - MRC Holland Kits

Please note before download:

  • Mix descriptions are only free of charge for customers with maintenance contract.
  • Don't hesitate to contact us, if there are any mix descriptions missing on this website.
  • To set up a new mix descriptions for you, still available at MRC Hollands website, please provide us the name of the mix (e.g. P002-D1), the version of the mix (e.g. Vs.02) and the date of its release.

  • To set up a new mix descriptions for you, not available at MRC Hollands website any more, please provide us the corresponding document by email or fax (+49-7822-440150-20).

Download

  • log into your SEQUENCE PILOT installation
  • go to category MLPA®
  • go to operation Mixes [master file]
  • press button [Import] and select the downloaded mme-file
  • if the corresponding mix already exists in your SEQUENE_PILOT installation you will be asked "Do you want to save the mix with a new name / lot?"; please press button [Yes] and complete the fields in the following dialogue; press button [OK] to save your entries
  • if the mix doesn't exist yet just press button [OK] in the following dialogue
MIX
VERSION
DATE
REGION
APPLICATION
DOWNLOAD
MIX
P320-A1
VERSION
Vs. 03
DATE
29-06-2011
REGION
17q, 18q, 19q, 20q.
APPLICATION
Subtelomeric screening
MIX
P320-A2
VERSION
Vs. A2-01
DATE
08-03-2018
REGION
17q, 18q, 19q, 20q
APPLICATION
Subtelomeric screening
MIX
P321-B2
VERSION
Vs. 08
DATE
05-02-2014
REGION
VPS13B 8q22
APPLICATION
Cohen syndrome
MIX
P321-B2
VERSION
Vs. 09
DATE
06-10-2016
REGION
VPS13B 8q22
APPLICATION
Cohen syndrome
MIX
P322-C1
VERSION
Vs. 08
DATE
05-02-2014
REGION
VPS13B 8q22
APPLICATION
Cohen syndrome
MIX
P322-C1
VERSION
Vs. 09
DATE
06-10-2016
REGION
VPS13B 8q22
APPLICATION
Cohen syndrome
MIX
P323-B1
VERSION
Vs.05
DATE
01-03-2013
REGION
CDK4-HMGA2-MDM2
APPLICATION
Liposarcomas
MIX
P324-A2
VERSION
Vs. 07
DATE
24-12-2012
REGION
22q11
APPLICATION
22q11
MIX
P324-A2
VERSION
Vs. 09
DATE
03-12-2015
REGION
22q11
APPLICATION
22q11
MIX
P325-A1
VERSION
Vs. 04
DATE
10-12-2015
REGION
OCA2 15q13
APPLICATION
oculocutaneous albinism
MIX
P325-A2
VERSION
Vs. 05
DATE
10-05-2017
REGION
OCA2 15q13
APPLICATION
oculocutaneous albinism
MIX
P326-A1
VERSION
Vs. 02
DATE
12-01-2011
REGION
LARGE, FKTN, POMT2
APPLICATION
Walter Wahlberg Syndrome
MIX
P326-A2
VERSION
Vs. 06
DATE
27-09-2013
REGION
LARGE, FKTN, POMT2
APPLICATION
Walter Wahlberg Syndrome
MIX
P327-A1
VERSION
Vs. 03
DATE
20-04-2010
REGION
IAMP21, RUNX1
APPLICATION
ALL, iAMP21
MIX
P327-B2
VERSION
Vs. 11
DATE
18-01-2017
REGION
iAMP21, RUNX1, ERG
APPLICATION
ALL, iAMP21
MIX
P328-A1
VERSION
Vs. 05
DATE
09-12-2015
REGION
EYS 6q12
APPLICATION
Retinitis Pigmentosa
MIX
P328-A2
VERSION
Vs. 06
DATE
23-03-2017
REGION
EYS 6q12
APPLICATION
Retinitis Pigmentosa
MIX
P329-A2
VERSION
Vs. 07
DATE
07-10-2015
REGION
Xp22.33
APPLICATION
ALL
MIX
P329-A2
VERSION
Vs. 08
DATE
18-04-2017
REGION
Xp22.33
APPLICATION
ALL
MIX
P330-A3
VERSION
Vs. 03
DATE
13-09-2016
REGION
PCDH19
APPLICATION
Epilepsy (EFMR)
MIX
P330-A3
VERSION
Vs. 04
DATE
31-08-2017
REGION
PCDH19
APPLICATION
Epilepsy (EFMR)
MIX
P331-B1
VERSION
Vs. 03
DATE
13-05-2015
REGION
COL5A1 9q34.3
APPLICATION
Ehlers-Danlos Syndrome
MIX
P331-B1
VERSION
Vs. 04
DATE
06-01-2017
REGION
COL5A1 9q34.3
APPLICATION
Ehlers-Danlos Syndrome
MIX
P332-B1
VERSION
Vs. 03
DATE
13-05-2015
REGION
COL5A1 9q34.3
APPLICATION
Ehlers-Danlos Syndrome
MIX
P332-C1
VERSION
Vs. 04
DATE
06-01-2017
REGION
COL5A1 9q34.3
APPLICATION
Ehlers-Danlos Syndrome
MIX
P333-A2
VERSION
Vs. 06
DATE
01-03-2013
REGION
EP300
APPLICATION
Rubinstein Taybi syndrome (RSTS)
MIX
P333-A3
VERSION
Vs. 08
DATE
05-10-2016
REGION
EP300
APPLICATION
Rubinstein Taybi syndrome (RSTS)
MIX
P334-A3
VERSION
Vs. 07
DATE
26-08-2015
REGION
DMRT1, CYP17A1, SRD5A2, HSD17B3
APPLICATION
Gonadal Development Disorder
MIX
P334-A4
VERSION
Vs. 08
DATE
12-10-2017
REGION
DMRT1, CYP17A1, SRD5A2, HSD17B3
APPLICATION
Gonadal Development Disorder
MIX
P335-B2
VERSION
Vs. 19
DATE
04-07-2016
REGION
IKZF1, PAX5, ETV6, RB1, BTG1, EBF1, CDKN2A-CDKN2B, Xp22.33
APPLICATION
acute lymphoblastic leukemia (ALL)
MIX
P335-C1
VERSION
Vs. C1-01
DATE
21-03-2018
REGION
IKZF1, PAX5, ETV6, RB1, BTG1, EBF1, CDKN2A-CDKN2B, Xp22.33
APPLICATION
acute lymphoblastic leukemia (ALL)
MIX
P336-A2
VERSION
Vs. 06
DATE
16-02-2016
REGION
UBE3A, MTHFR, GABRB3, AXIN1
APPLICATION
Angelman
MIX
P336-B1
VERSION
Vs. 07
DATE
08-11-2016
REGION
UBE3A, MTHFR, GABRB3, AXIN1
APPLICATION
Angelman
MIX
P337-B1
VERSION
Vs. 07
DATE
01-06-2015
REGION
TSC2 gene, 16p13.3
APPLICATION
Tuberous sclerosis
MIX
P337-B1
VERSION
Vs. 08
DATE
02-08-2016
REGION
TSC2 gene, 16p13.3
APPLICATION
Tuberous sclerosis
MIX
P338-B1
VERSION
Vs. 06
DATE
18-08-2016
REGION
GBA 1q22
APPLICATION
Gaucher disease
MIX
P339-A1
VERSION
Vs. 04
DATE
01-03-2013
REGION
SHANK3 22q13.33
APPLICATION
Autism Spectrum Disorder
MIX
P339-B1
VERSION
Vs. 06
DATE
02-10-2015
REGION
SHANK3 22q13.33
APPLICATION
Autism Spectrum Disorder